Search results
Results From The WOW.Com Content Network
In order to keep the patent rights for the entire period, India's Patent Act has made it mandatory for the patent holders to pay a renewal fee. [17] Once the patent is granted the patentee does not need to pay a renewal or maintenance fee for the first two years. The first renewal fee will be payable from the third year onwards. [18]
Useful (in U.S. patent law) or be susceptible of industrial application (in European patent law [1]) Usually the term "patentability" only refers to the four aforementioned "substantive" conditions, and does not refer to formal conditions such as the "sufficiency of disclosure", the "unity of invention" or the "best mode requirement".
A request for limitation or revocation can only be filed by the proprietor(s) of the patent. [1] [9] The request may be filed at any time [1] throughout the entire term of the European patent. [10] [11] According to the Guidelines, the request can even be filed after expiry of the patent. [12]
The economic effects of intellectual property reform in India is a complex subject area, and would require a separate detailed article. A beginning may be made by referring to Sunil Kanwar and Stefan Sperlich (2020), [18] who study the effect of intellectual property reform on technological advancement and productivity increases in manufacturing industry in the emerging market context of India.
A patent is a type of intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. [1] In most countries, patent rights fall under private law and the patent holder must sue someone ...
The Protection of Plant Variety and Farmers Right Act, 2001 (PPVFR Act) is an Act of the Parliament of India that was enacted to provide for the establishment of an effective system for the protection of plant varieties, the rights of farmers and plant breeders, and to encourage the development and cultivation of new varieties of plants.
Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the patent application.
If a party files an opposition to a European patent with the EPO, that party may in most countries (except in Germany [80]) also, in parallel, initiate a revocation action (also called "nullity action" or "validity proceedings") against the same patent before a national court (or the UPC). In such a case, the national court (or the UPC) may, at ...